SN

Sanjana Narayan

Active Director Director DIN 11974278
DIN 11974278 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjana Narayan

Sanjana Narayan is a Director at Zeng Biotech Private Limited (since 2026).

DIN 11974278
Primary Designation Director
First Appointment 28 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zeng Biotech Private Limited U46909GJ2026PTC184348
Director28 Sep 20262026Active

Board colleagues of Sanjana Narayan

NameDINCompanyDesignation
Dimpal Sharma11974277Zeng Biotech Private LimitedDirector
Renu Kumari11974279Zeng Biotech Private LimitedDirector
U46909gj2026ptc184348 U46909gj2026ptc184348Zeng Biotech Private LimitedCompany/Llp

Directorship timeline

Open interactive timeline →
Zeng Biotech Private Limited
Premium access

Shareholding and investment profile for Sanjana Narayan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjana Narayan

Sanjana Narayan currently holds 1 directorship: Zeng Biotech Private Limited (Director, since 28 Sep 2026).

Sanjana Narayan was first appointed on 28 Sep 2026 as Director at Zeng Biotech Private Limited.

The current boards of Sanjana Narayan's companies include Dimpal Sharma (Zeng Biotech Private Limited), Renu Kumari (Zeng Biotech Private Limited), U46909gj2026ptc184348 U46909gj2026ptc184348 (Zeng Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available